Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex.

MLA

Sun, Yilun, et al. “Targeting Neddylation Sensitizes Colorectal Cancer to Topoisomerase I Inhibitors by Inactivating the DCAF13-CRL4 Ubiquitin Ligase Complex.” Nature Communications, vol. 14, no. 1, June 2023, p. 3762. EBSCOhost, https://doi.org/10.1038/s41467-023-39374-9.

APA

Sun, Y., Baechler, S. A., Zhang, X., Kumar, S., Factor, V. M., Arakawa, Y., Chau, C. H., Okamoto, K., Parikh, A., Walker, B., Su, Y. P., Chen, J., Ting, T., Huang, S.-Y. N., Beck, E., Itkin, Z., McKnight, C., Xie, C., Roper, N., … Pommier, Y. (2023). Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex. Nature Communications, 14(1), 3762. https://doi.org/10.1038/s41467-023-39374-9

Chicago

Sun, Yilun, Simone A Baechler, Xiaohu Zhang, Suresh Kumar, Valentina M Factor, Yasuhiro Arakawa, Cindy H Chau, et al. 2023. “Targeting Neddylation Sensitizes Colorectal Cancer to Topoisomerase I Inhibitors by Inactivating the DCAF13-CRL4 Ubiquitin Ligase Complex.” Nature Communications 14 (1): 3762. doi:10.1038/s41467-023-39374-9.